Stock Analysis

Nama Chemicals Company (TADAWUL:2210) Investors Are Less Pessimistic Than Expected

It's not a stretch to say that Nama Chemicals Company's (TADAWUL:2210) price-to-sales (or "P/S") ratio of 1.9x right now seems quite "middle-of-the-road" for companies in the Chemicals industry in Saudi Arabia, where the median P/S ratio is around 1.8x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.

View our latest analysis for Nama Chemicals

ps-multiple-vs-industry
SASE:2210 Price to Sales Ratio vs Industry March 28th 2025
Advertisement

How Has Nama Chemicals Performed Recently?

As an illustration, revenue has deteriorated at Nama Chemicals over the last year, which is not ideal at all. Perhaps investors believe the recent revenue performance is enough to keep in line with the industry, which is keeping the P/S from dropping off. If not, then existing shareholders may be a little nervous about the viability of the share price.

Although there are no analyst estimates available for Nama Chemicals, take a look at this free data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.

Is There Some Revenue Growth Forecasted For Nama Chemicals?

The only time you'd be comfortable seeing a P/S like Nama Chemicals' is when the company's growth is tracking the industry closely.

In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 17%. This means it has also seen a slide in revenue over the longer-term as revenue is down 28% in total over the last three years. Accordingly, shareholders would have felt downbeat about the medium-term rates of revenue growth.

Comparing that to the industry, which is predicted to deliver 3.2% growth in the next 12 months, the company's downward momentum based on recent medium-term revenue results is a sobering picture.

With this in mind, we find it worrying that Nama Chemicals' P/S exceeds that of its industry peers. It seems most investors are ignoring the recent poor growth rate and are hoping for a turnaround in the company's business prospects. There's a good chance existing shareholders are setting themselves up for future disappointment if the P/S falls to levels more in line with the recent negative growth rates.

What Does Nama Chemicals' P/S Mean For Investors?

It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

Our look at Nama Chemicals revealed its shrinking revenues over the medium-term haven't impacted the P/S as much as we anticipated, given the industry is set to grow. Even though it matches the industry, we're uncomfortable with the current P/S ratio, as this dismal revenue performance is unlikely to support a more positive sentiment for long. Unless the the circumstances surrounding the recent medium-term improve, it wouldn't be wrong to expect a a difficult period ahead for the company's shareholders.

We don't want to rain on the parade too much, but we did also find 2 warning signs for Nama Chemicals that you need to be mindful of.

Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

Valuation is complex, but we're here to simplify it.

Discover if Nama Chemicals might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SASE:2210

Nama Chemicals

NAMA Chemicals Company, together with its subsidiaries, owns, operates, and manages industrial projects in the petrochemical and chemical sectors in Saudi Arabia, the Gulf countries, Asia, Africa, Europe, and other territories.

Slightly overvalued with questionable track record.

Advertisement

Weekly Picks

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8228.9% undervalued
46 users have followed this narrative
4 users have commented on this narrative
28 users have liked this narrative
WO
BMBL logo
woodworthfund on Bumble ·

Swiped Left by Wall Street: The BMBL Rebound Trade

Fair Value:US$960.9% undervalued
15 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ·

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6435.3% undervalued
31 users have followed this narrative
5 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

YI
GOOGL logo
yiannisz on Alphabet ·

The Real Power Behind Alphabet’s Growth

Fair Value:US$192.5469.0% overvalued
22 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
YI
RELX logo
yiannisz on RELX ·

RELX: The Quiet Compounder Powering Law, Science, and Risk Intelligence

Fair Value:US$41.222.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
CVS logo
yiannisz on CVS Health ·

Why CVS’s Valuation Signals Opportunity

Fair Value:US$104.0122.5% undervalued
102 users have followed this narrative
9 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.4% undervalued
70 users have followed this narrative
13 users have commented on this narrative
23 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0226.9% undervalued
1030 users have followed this narrative
6 users have commented on this narrative
29 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25411.3% overvalued
72 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative